Position in NVO
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,964,561
+$1,082,778 QoQ
Shares Held
61,839
+20.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#298
of 1,348 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $225,886,114 across 15 Drug Manufacturers - General names. NVO ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
78,924 | $94,663,821 | |
| 2 | JNJ |
Johnson & Johnson
|
176,284 | $44,770,847 | |
| 3 | ABBV |
AbbVie Inc.
|
132,322 | $33,297,508 | |
| 4 | MRK |
Merck & Co., Inc.
|
176,330 | $22,658,405 | |
| 5 | AMGN |
Amgen Inc
|
32,937 | $11,927,146 | |
| 6 | NVS |
Novartis AG
|
71,102 | $11,143,105 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
61,839 | $2,964,561 | |
| 8 | PFE |
Pfizer Inc
|
106,893 | $2,573,983 |
All Filings in NVO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,964,561 | 61,839 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,881,783 | 51,205 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $493,128 | 9,692 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,055,863 | 19,028 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,316,556 | 19,075 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1,630,104 | 23,475 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,886,074 | 21,926 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,552,265 | 21,435 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,825,966 | 19,798 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $1,728,264 | 13,460 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $221,589 | 2,142 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $194,793 | 2,142 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $132,538 | 819 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $213,088 | 1,339 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $181,220 | 1,339 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $896 | 9 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,002 | 9 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $999 | 9 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,008 | 9 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $864 | 9 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $753 | 9 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $606 | 9 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $628 | 9 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||